title: Evidence that hypothalamic neuropeptide Y gene expression increases before the onset of the preovulatory LH surge.
abstract: Neuropeptide Y (NPY), a 36 amino acid residue peptide, is involved in stimulation of LHRH and LH surges on proestrus and those induced by ovarian steroids in ovariectomized (ovx) rats. Recently, we observed that NPY gene expression in the medial basal hypothalamus (MBH) was increased before the onset of the LH surge in the ovarian steroid-primed ovx rats. Since the ovarian steroidal milieu during the estrous cycle is markedly different from that prevailing after ovarian steroid injections in ovx rats, we evaluated in cycling rats the temporal relationship between MBH preproNPY mRNA levels and the preovulatory LH surge on the day of proestrus and compared that with diestrus II, concomitant with basal LH levels. PreproNPY mRNA levels in the MBH were measured by solution hybridization/RNAse protection assay, using a cRNA probe. On the day of diestrus II, preproNPY mRNA levels changed little between 1000 and 1800 h. Quite unexpectedly, preproNPY mRNA levels at 1000 h on proestrus were similar to diestrus II levels, despite additional exposure to ovarian steroids during this interval. However, from these low levels at 1000 h, the preproNPY mRNA profile displayed a biphasic rise. During the first phase, preproNPY mRNA rose significantly at 1200 h and remained elevated at 1300 and 1400 h concomitant with basal serum LH levels. Thereafter, a second rise in preproNPY mRNA began at 1500 h, peaked rapidly at 1600 h and declined significantly at 1800 h.(ABSTRACT TRUNCATED AT 250 WORDS)
authors.affiliation: Department of Neuroscience, University of Florida College of Medicine, Gainesville 32610, USA.
authors.forename: A
authors.initials: A
authors.lastname: Sahu
authors.forename: W R
authors.initials: WR
authors.lastname: Crowley
authors.forename: S P
authors.initials: SP
authors.lastname: Kalra
mesh_terms: D000704:Analysis of Variance; D000818:Animals; D004031:Diestrus / Q000187:drug effects; D015914:Estrogen Replacement Therapy; D004967:Estrogens / Q000502:physiology*; D005260:Female; D005498:Follicular Phase; D005786:Gene Expression Regulation / Q000187:drug effects*; D007033:Hypothalamus, Middle / Q000378:metabolism*; D007986:Luteinizing Hormone / Q000378:metabolism*; D009478:Neuropeptide Y / Q000235:genetics*; D011359:Proestrus / Q000187:drug effects; D011374:Progesterone / Q000502:physiology*; D051381:Rats; D012636:Secretory Rate
chemical_list: D004967:Estrogens; D009478:Neuropeptide Y; D011374:Progesterone; D007986:Luteinizing Hormone